scholarly article | Q13442814 |
P356 | DOI | 10.1002/(SICI)1097-4547(19960201)43:3<289::AID-JNR4>3.0.CO;2-F |
P698 | PubMed publication ID | 8714518 |
P2093 | author name string | Antel JP | |
Alinauskas KA | |||
D'Souza SD | |||
P2860 | cites work | Peripheral blood ?-? T cells lyse fresh human brain?Derived oligodendrocytes | Q48613619 |
Morphological changes in oligodendrocytes in the intact mouse optic nerve following intravitreal injection of tumour necrosis factor. | Q52514686 | ||
Tumor necrosis factor inhibits K+ current expression in cultured oligodendrocytes. | Q54286323 | ||
Multiple sclerosis: oligodendrocytes in active lesions do not express class II major histocompatibility complex molecules. | Q54636938 | ||
Natural and induced cytotoxicity of oligodendrocytes by microglia is inhibitable by TGF beta | Q67902817 | ||
Direct injection of cytokines into the spinal cord causes autoimmune encephalomyelitis-like inflammation | Q68382327 | ||
Antigen expression by glial cells grown in culture | Q68934518 | ||
Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro | Q70392550 | ||
Oligodendrocyte lysis by CD4+ T cells independent of tumor necrosis factor | Q71613264 | ||
Phenotypic and cell cycle properties of human oligodendrocytes in vitro | Q72235437 | ||
Effects of tumor necrosis factor on inward potassium current and cell morphology in cultured human oligodendrocytes | Q72618205 | ||
Cell death and control of cell survival in the oligodendrocyte lineage | Q34460930 | ||
Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group | Q34730962 | ||
A role for TGF-beta in oligodendrocyte differentiation | Q36232939 | ||
Development of oligodendrocytes and Schwann cells studied with a monoclonal antibody against galactocerebroside | Q36292898 | ||
An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis | Q36353675 | ||
The binding and lysis of target cells by cytotoxic lymphocytes: molecular and cellular aspects | Q40661193 | ||
Multiple sclerosis: immune system molecule expression in the central nervous system | Q40666815 | ||
Programmed cell death and the control of cell survival: lessons from the nervous system | Q40777905 | ||
Immune and non-immune actions of interferon-beta-Ib on primary human neural cells | Q41351934 | ||
Regulation of an oligodendrocyte progenitor cell line by the interleukin-6 family of cytokines | Q41440638 | ||
CNTF receptor alpha mRNA expression in rodent cell lines and developing rat. | Q41446261 | ||
Characteristics of in vitro cytotoxic effects of myelin basic protein-reactive T cell lines on syngeneic oligodendrocytes | Q41757496 | ||
Immunohistochemical studies of adult human glial cells | Q42505059 | ||
CNS glial cells express neurotrophin receptors whose levels are regulated by NGF. | Q42507439 | ||
Anti?tumor necrosis factor therapy abrogates autoimmune demyelination | Q43924367 | ||
Tumour necrosis factor causes an increase in axonal transport of protein and demyelination in the mouse optic nerve | Q44635103 | ||
Normal rat serum cytotoxicity against syngeneic oligodendrocytes. Complement activation and attack in the absence of anti-myelin antibodies. | Q45147036 | ||
Cytokines and murine autoimmune encephalomyelitis: inhibition or enhancement of disease with antibodies to select cytokines, or by delivery of exogenous cytokines using a recombinant vaccinia virus system | Q45784536 | ||
In vitro evidence for a dual role of tumor necrosis factor‐α in human immunodeficiency virus type 1 encephalopathy | Q45786587 | ||
CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death. | Q46020332 | ||
Myelin basic protein content of aggregating rat brain cell cultures treated with cytokines and/or demyelinating antibody: effects of macrophage enrichment | Q46845557 | ||
A crucial role for neurotrophin-3 in oligodendrocyte development | Q48188523 | ||
Injury-induced regulation of ciliary neurotrophic factor mRNA in the adult rat brain | Q48379221 | ||
Recombinant human ciliary neurotrophic factor alters the threshold of hippocampal pyramidal neuron sensitivity to excitotoxin damage: synergistic effects of monosialogangliosides | Q48427373 | ||
Mechanisms of oligodendrocyte interaction with normal human serum - defining the role of complement | Q48512045 | ||
P433 | issue | 3 | |
P921 | main subject | oligodendrocyte | Q916698 |
P304 | page(s) | 289-298 | |
P577 | publication date | 1996-02-01 | |
P1433 | published in | Journal of Neuroscience Research | Q6295654 |
P1476 | title | Ciliary neurotrophic factor selectively protects human oligodendrocytes from tumor necrosis factor-mediated injury | |
P478 | volume | 43 |
Q43825678 | Astrocytes attenuate oligodendrocyte death in vitro through an alpha(6) integrin-laminin-dependent mechanism |
Q48706908 | Astrogliosis in the neonatal and adult murine brain post-trauma: elevation of inflammatory cytokines and the lack of requirement for endogenous interferon-gamma |
Q79145512 | CNTF-activated astrocytes release a soluble trophic activity for oligodendrocyte progenitors |
Q40903065 | Caspases mediate C2-ceramide-induced apoptosis of the human oligodendroglial cell line, MO3.13. |
Q48367992 | Ceramide inhibits inwardly rectifying K+ currents via a Ras- and Raf-1-dependent pathway in cultured oligodendrocytes. |
Q48198699 | Characterization of mature rat oligodendrocytes: a proteomic approach |
Q35221952 | Continued administration of ciliary neurotrophic factor protects mice from inflammatory pathology in experimental autoimmune encephalomyelitis. |
Q40762931 | Cyclic AMP differentiation of the oligodendroglial cell line N20.1 switches staurosporine-induced cell death from necrosis to apoptosis |
Q77903811 | Cytokine actions in the central nervous system |
Q44023205 | Disialoganglioside GD3 is released by microglia and induces oligodendrocyte apoptosis |
Q74297214 | Elevated cerebrospinal fluid level of ciliary neurotrophic factor in acute disseminated encephalomyelitis |
Q58425792 | Endogenous leukemia inhibitory factor production limits autoimmune demyelination and oligodendrocyte loss |
Q24337862 | Gas6/Axl signaling activates the phosphatidylinositol 3-kinase/Akt1 survival pathway to protect oligodendrocytes from tumor necrosis factor alpha-induced apoptosis |
Q34398657 | Glial cells as targets for cytotoxic immune mediators |
Q42444225 | Glial reactivity in ciliary neurotrophic factor-deficient mice after optic nerve lesion. |
Q41589718 | Growth factors and myelin regeneration in multiple sclerosis |
Q73109180 | Interleukin-6 expression in human multiple sclerosis lesions |
Q58425803 | LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival |
Q37085783 | Lame ducks or fierce creatures? The role of oligodendrocytes in multiple sclerosis |
Q49059546 | Lipopolysaccharide administration in vivo induces differential expression of cAMP-specific phosphodiesterase 4B mRNA splice variants in the mouse brain. |
Q41712461 | Macrophages in CNS remyelination: friend or foe? |
Q37625399 | Molecular features of neural stem cells enable their enrichment using pharmacological inhibitors of survival-promoting kinases |
Q36377383 | Multiple sclerosis: Fas signaling in oligodendrocyte cell death |
Q60684621 | Nerve Growth Factor Protects Oligodendrocytes from Tumor Necrosis Factor-α-induced Injury through Akt-mediated Signaling Mechanisms |
Q36166488 | Neural stem cells in inflammatory CNS diseases: mechanisms and therapy. |
Q47892533 | Neurotrophin-3 and brain-derived neurotrophic factor induce oligodendrocyte proliferation and myelination of regenerating axons in the contused adult rat spinal cord. |
Q30355283 | Nudging oligodendrocyte intrinsic signaling to remyelinate and repair: Estrogen receptor ligand effects. |
Q48510916 | Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity |
Q33671711 | Overexpression of the astrocyte glutamate transporter GLT1 exacerbates phrenic motor neuron degeneration, diaphragm compromise, and forelimb motor dysfunction following cervical contusion spinal cord injury. |
Q77421414 | Photoreceptor rescue |
Q47841614 | Puma, but not noxa is essential for oligodendroglial cell death |
Q31910504 | Role of calcium in nitric oxide-induced cytotoxicity: EGTA protects mouse oligodendrocytes |
Q51321537 | Sex-related differences of cAMP-specific PDE4B3 mRNA in oligodendrocytes following systemic inflammation. |
Q41841345 | Signal transduction of stress via ceramide |
Q48635220 | Target depletion of distinct tumor necrosis factor receptor subtypes reveals hippocampal neuron death and survival through different signal transduction pathways. |
Q36571196 | The pathophysiology of ischemic injury to developing white matter |
Q35180002 | The role of the JAK-STAT pathway in neural stem cells, neural progenitor cells and reactive astrocytes after spinal cord injury |
Q74587444 | Understanding glial abnormalities associated with myelin deficiency in the jimpy mutant mouse |
Search more.